Answers are grounded in this paper and cite their sources.
We have identified solutions to key challenges in probiotic design to create a commercially viable strain for the removal of the intestinal toxin acetaldehyde. Here we report engineering of a σ D -dependent flagellin expression locus, hag, as a stable location for robust enzyme production. We demonstrate constitutive gene expression in relevant conditions driven by the endogenous hag promoter following a deletion of the gene encoding a post-translational regulator of σ D , FlgM, and a point mutation to abrogate the binding of the translational inhibitor CsrA. Reporter constructs demonstrate hag locus activity after germination and show a steady increase in heterologous expression throughout outgrowth and resumption of vegetative growth. To test the chassis as a spore-based probiotic solution we identified the physiologically relevant pathway of ethanol metabolism and the buildup of gut-derived acetaldehyde after alcohol consumption. Herein, we describe the integration of a robustly expressed Cupriavidus necator aldehyde dehydrogenase, AcoD, under a flagellin protein promoter at the hag locus and report the rapid reduction of acetaldehyde levels after germination in gut simulated conditions.
No takes yet. Share an insight, caveat, or question.
Hassan-Casarez et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: